Doxycycline Hyclate NDC 43547-325

NDC codes

FDA NDC Directory

Product NDC (as listed)43547-325Labeler and product segments. Claims need a package NDC.

Product NDC at billing width43547-0325Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
43547-325-06	43547032506	60 TABLET, DELAYED RELEASE in 1 BOTTLE (43547-325-06)Marketed from Nov 28, 2016
43547-325-10	43547032510	100 TABLET, DELAYED RELEASE in 1 BOTTLE (43547-325-10)Marketed from Nov 28, 2016
43547-325-50	43547032550	500 TABLET, DELAYED RELEASE in 1 BOTTLE (43547-325-50)Marketed from Nov 28, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Doxycycline Hyclate
Generic name (nonproprietary): doxycycline hyclate
Active ingredients: Doxycycline hyclate — 200 mg/1
Dosage form: Tablet, Delayed release
Route: Oral
Labeler: Solco Healthcare US LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207494
Marketing start: Nov 28, 2016
Listing expires: Dec 31, 2027
Other FDA classes: Tetracyclines (Chemical structure)
Identifiers: Product ID 43547-325_49c9be01-a1bf-48aa-8ef4-0584e8dcaac5SPL ID 49c9be01-a1bf-48aa-8ef4-0584e8dcaac5SPL set ID 0a18d4c7-9484-4d3e-b61b-e81fe63fefecRxCUI 799048, 1423080, 1653433UNII 19XTS3T51UUPC 0343547325060, 0343547324063, 0343547462123
Pharmacologic class: Tetracycline-class Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N443547032506 followed by a unit qualifier and the quantity

Package 43547-0325-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 31, 2025.

Indications (excerpt from the label)

Doxycycline hyclate delayed-release tablets are a tetracycline-class drug indicated for: • Rickettsial infections ( 1.1 ) • Sexually transmitted infections ( 1.2 ) • Respiratory tract infections ( 1.3 ) • Specific bacterial infections ( 1.4 ) • Ophthalmic infections ( 1.5 ) • Anthrax, including inhalational anthrax (post-exposure) ( 1.6 ) • Alternative treatment for selected infections when penicillin is contraindicated ( 1.7 ) • Adjunctive therapy in acute intestinal amebiasis and severe acne ( 1.8 ) • Prophylaxis of malaria ( 1.9 ) Usage To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate delayed-release tablets and other antibacterial…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 207494

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207494
Product	Strength	Form · route	Labeler	Product NDC
Doxycycline Hyclate	Doxycycline hyclate 150 mg/1	Tablet, Delayed releaseOral	Sonoma Pharmaceuticals, Inc.	69668-515
Doxycycline Hyclate	Doxycycline hyclate 50 mg/1	Tablet, Delayed releaseOral	Solco Healthcare US LLC	43547-462
Doxycycline Hyclate	Doxycycline hyclate 150 mg/1	Tablet, Delayed releaseOral	Solco Healthcare US LLC	43547-324